1. Home
  2. NMTC vs AMSS Comparison

NMTC vs AMSS Comparison

Compare NMTC & AMSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

BUY

Current Price

$1.07

Market Cap

29.2M

Sector

Health Care

ML Signal

BUY

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

HOLD

Current Price

$0.36

Market Cap

30.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMTC
AMSS
Founded
2009
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
29.2M
30.6M
IPO Year
2010
2026

Fundamental Metrics

Financial Performance
Metric
NMTC
AMSS
Price
$1.07
$0.36
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.27
N/A
AVG Volume (30 Days)
★ 148.8K
145.3K
Earning Date
08-13-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 80.43
N/A
EPS
★ N/A
N/A
Revenue
★ $9,097,692.00
N/A
Revenue This Year
N/A
$3.71
Revenue Next Year
$26.57
$20.00
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 163.47
N/A
52 Week Low
$0.61
$0.32
52 Week High
$12.24
$2.44

Technical Indicators

Market Signals
Indicator
NMTC
AMSS
Relative Strength Index (RSI) 33.72 27.06
Support Level $0.96 N/A
Resistance Level $1.35 $0.81
Average True Range (ATR) 0.11 0.07
MACD 0.02 0.00
Stochastic Oscillator 27.26 10.34

Price Performance

Historical Comparison
NMTC
AMSS

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

Share on Social Networks: